You are viewing a historical snapshot of India (NSE / BSE). These figures are a preview to show what TradeTidings covers. Live, continuously updated India sentiment and stock impact is a Pro feature.
Get live India data with ProZydus Lifesciences Ltd. (ZYDUSLIFE)
4 stories published on ZYDUSLIFE since June 2026. See all coverage.
News sentiment trend
Counts of positive, neutral, and negative news items over the last 90 days. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Sentiment timeline
How news sentiment on Zydus Lifesciences Ltd. (ZYDUSLIFE) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
Why this reading
The recent items weighing most on this reading, by direction and influence.
Zydus Lifesciences Stock: Company Seals $150 Million Sterling Biotech Deal
Direct news · Medium influence · Long term
Zydus Lifesciences Stock: FY26 Annual Report Flags Record Revenue and New Acquisitions
Direct news · Medium influence · Long term
Zydus Lifesciences Stock in Focus as US Oncology Drug Shortages Create an Opening
Direct news · Medium influence · Short term
Zydus Lifesciences Extends Sterling Biotech Acquisition Deadline to September 30, 2026
Direct news · Low influence · Short term
Direct news
The most recent stories naming ZYDUSLIFE directly, across all of our coverage.
Zydus Lifesciences Stock: Company Seals $150 Million Sterling Biotech Deal
Zydus Lifesciences Stock: FY26 Annual Report Flags Record Revenue and New Acquisitions
Zydus Lifesciences Stock in Focus as US Oncology Drug Shortages Create an Opening
Zydus Lifesciences Extends Sterling Biotech Acquisition Deadline to September 30, 2026
Indirect drivers in the news
Macro, commodity, FX and regulatory forces that have moved ZYDUSLIFE, with the stories behind each.
No indirect-driver news for ZYDUSLIFE in our coverage yet.
Also monitored for ZYDUSLIFE (no news in our coverage yet): US FDA / USFDA, Indian rupee / INR-USD.
See the full picture
Sign up free to track ZYDUSLIFE, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track ZYDUSLIFE for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.